In the Mediterranean area, 50% of the , thalassaemia mutations abolish or create a restriction endonuclease site in the globin gene. This study describes a new procedure for prenatal detection of these ,B thalassaemia defects based on the direct visualisation, on an ethidium bromide stained polyacrylamide gel, of the discrete DNA fragments produced by restriction endonuclease digestion of fetal DNA, enzymatically amplified using the DNA polymerase from the thermophilus bacterium Thermus aquaticus. We applied this procedure to the Sardinian population to detect the nonsense mutation at codon 39 and the frameshift at codon 6 of the ,1 globin gene; these are the most frequent 13 thalassaemia mutations in this population, accounting for 95% and 2-2% of the , thalassaemia chromosomes. The main advantages of this procedure are simplicity (no radioactivity), sensitivity (0-2 Ftg of DNA), and rapidity (12 hours 
Prenatal diagnosis of a thalassaemia is nowadays
accomplished by fetal DNA analysis.' The methods currently used are based on the direct detection of ,3 thalassaemia mutations by restriction endonuclease analysis2 3 and oligonucleotide hybridisation48 or on indirect identification by linkage analysis with restriction fragment length polymorphisms (RFLPs) in the j3 globin gene cluster. ' 
Discussion
This study shows that prenatal detection of thalassaemia mutations affecting a restriction endonuclease site can be accomplished by direct visualisation under ultraviolet light on an ethidium bromide stained polyacrylamide gel, after electrophoresis, of the discrete DNA fragments produced by restriction endonuclease digestion of enzymatically amplified globin gene sequences. In our experience, which agrees with previously described studies,'2 20 the use of the thermostable DNA polymerase was crucial for obtaining these results. The assay conditions, such as high temperature, required for the optimal activity of the DNA polymerase, increase the specific annealing of the two oligonucleotide primers with their complementary sequences in the genomic DNA. Thus, a large amount of pure target DNA fragment is obtained.
One of the problems encountered in prenatal diagnosis using restriction endonuclease analysis is the possibility of misdiagnosis owing to incomplete digestion of the fetal DNA by the enzyme. We decided to amplify a region of the 13 globin gene which, in addition to the restriction enzyme site affected by the 1339 and 136 mutations (MaeI and OxaNI respectively), includes other sites for the same enzymes, both in the normal and in the mutated genes. Thus, complete digestion of the amplified DNA is guaranteed by the lack of the undigested amplified fragment independently of the specific fragment pattern determined by the presence or the absence of the mutation. The possibility of monitoring the restriction enzyme digestion of the amplified DNA improves the reliability of this method. In the detection of specific 13 thalassaemia mutations by the procedure described here on enzymatically amplified DNA, a potential problem is maternal cell contamination. The most critical situation regards fetuses homozygous for 13 thalassaemia who, because of maternal contamination, may be misdiagnosed as heterozygotes. In order to avoid misdiagnosis, first the placental tissue should be accurately dissected from the trophoblasts under a microscope. Maternal cell contamination can usually be detected by the presence on the gel of a faint band(s) from the normal chromosome, along with bands of more marked intensity from the 13 thalassaemia chromosomes.
The main advantages of this procedure are simplicity, sensitivity, and rapidity. Molecular probes are no longer necessary, making this method very suitable even for routine laboratories. Avoiding radioactive and non-radioactive probes may allow prenatal diagnosis by DNA analysis to be extended to those places where thalassaemia is frequent and the purchase of radioactive material is difficult. DNA amplification using thermostable DNA polymerase produces a 106-fold increase in the amount of target sequences. This allows us to carry out prenatal diagnosis with as little as 0*2 [tg of DNA and to obtain the result very rapidly, approximately within 12 to 24 hours of the fetal sampling.
The application of this method to amniocyte DNA analysis is extremely useful as cell culture is no longer necessary, thus reducing the time required for the diagnosis from four weeks to a few days. The successful amplification from a crude cell lysate prepared from as little as 1-0 ml of amniotic fluid further simplifies the procedure, eliminating the step of DNA preparation.
We can also predict that the reduction in the amount of fetal material necessary for the analysis may result in a decrease in the risk of fetal loss associated with trophoblast sampling. In this study we amplified a region of the ,3 globin gene which contains the large majority of the known j3 thalassaemia mutations, including the P039 and I3°6 mutations, the former being the most frequent , thalassaemia mutation in the western part of the Mediterranean area.21 22 
